Brown Ryan Edward

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Brown Ryan Edward's trades of Sarepta Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-25 2024-06-25
PrS Proposed sale
93,714
345.65
US$2,759,924 		93,714 345.65 US$2,759,924
2024-06-25 2024-06-25
PlS Planned sale
40,959 +42.1%
110.40
US$4,634,532 		40,959 +42.1% 110.40 US$4,634,532
2024-06-25 2024-06-25
PlS Planned sale
13,420 +6.8%
386.48
US$3,347,605 		13,420 +6.8% 386.48 US$3,347,605
2024-06-25 2024-06-25
PlS Planned sale
17,581 -42.8%
162.65
US$2,859,550 		17,581 -42.8% 162.65 US$2,859,550
2024-06-25 2024-06-25
PlS Planned sale
4,168 -9.2%
161.82
US$674,466 		4,168 -9.2% 161.82 US$674,466
2024-06-25 2024-06-25
PlS Planned sale
975 -2.1%
160.31
US$156,302 		975 -2.1% 160.31 US$156,302
2024-06-25 2024-06-25
PlS Planned sale
2,200 -4.5%
159.14
US$350,108 		2,200 -4.5% 159.14 US$350,108
2024-06-25 2024-06-25
PlS Planned sale
7,644 -13.6%
158.07
US$1,208,287 		7,644 -13.6% 158.07 US$1,208,287
2024-03-05 2024-03-01
S Sale
2,000 -5.9%
125.34
US$250,680 		2,000 -5.9% 125.34 US$250,680
2024-03-01 2024-03-01
PrS Proposed sale
2,269
125.44
US$284,635 		2,269 125.44 US$284,635